Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis
(1) Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Ground floor of Baqiyatallah Hospital, Mollasadra Ave., Vanak Sq., P.O. Box 14155-3651, Tehran, Iran
Abstract:
Background
About one-half of patients with hepatitis C genotype 1 and one-third with genotype 2/3 have treatment failure with peginterferon
alpha and ribavirin. Consensus interferon (CIFN) is an option for retreatment of these patients.